|
 |
TemozolomideThis page contains recent news articles, when available, and an overview of Temozolomide but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Temozolomide (when available) Temozolomide is an antineoplastic agent. It causes death of of rapidly replicating cells, especially malignant cells, leading to regression or slowed tumor growth. For the treatment of adult patients diagnosed with anaplastic astrocytoma who have relapsed following chemotherapy Mechanism Of Action: Temozolomide is not active until it is converted at physiologic pH to the active form, 5-(3-methyltriazen-1-yl)imidazole-4-carboxamide (MTIC). The cytotoxicity of MTIC is due to alkylation of DNA at the O6 and N7 positions of guanine. News Articles on Temozolomide OncoMethylome Sciences to Perform MGMT Testing in Roche Phase III Study of ... - 05 Jan 2010 This trial will compare the current standard-of-care therapy, which is concurrent chemoradiation and adjuvant temozolomide "TMZ" (Temodar Ã’ ... istockAnalyst.com (press release) Geron Announces Publication of Data on Its Telomerase Inhibitor in Glioblastoma - 05 Jan 2010 In addition, temozolomide and ionizing radiation, standard treatment regimens for glioblastoma after surgical resection, boost the effects of imetelstat, ... Earthtimes (press release) EU Panel Backs DuoCover From Bristol-Myers Squibb Pharma - Dec 18, 2009 ...-The Committee adopted positive opinions for Temozolomide Hexal (temozolomide), from Hexal AG, Temozolomide Sandoz (temozolomide), ... Wall Street Journal Committee For Medicinal Products For Human Use Summary Of Positive Opinion ... - Dec 18, 2009 The applicant for this medicinal product is Hospira UK Ltd. The active substance of Temozolomide Hospira is temozolomide, an antineoplastic and ... PharmaLive.com (press release) Scientists improve results of chemo drug - Dec 14, 2009 14 (UPI) -- US scientists say they've found adding a small molecule to the chemotherapy drug Temozolomide hikes its effectiveness at a much smaller dosage. ... UPI.com OTCMarketbulls.com Reports Hot Market Movers For December 28, 2009 - eDOORWAYS ... - Dec 29, 2009 Patients with metastatic melanoma often are treated off-label with drugs such as temozolomide, which has been approved by the FDA for the treatment of ... TMCnet Allovectin-7 For Melanoma Treatment Passes Third Safety Analysis - Dec 28, 2009 Allovectin-7® and approximately 125 will be treated with their physician's choice of either of two chemotherapy agents, dacarbazine or temozolomide. ... eMaxHealth Detroit Wrongful Death Lawsuit Filed Over Pharmacy Error - Dec 28, 2009 Temodar (temozolomide) is an antineoplastic agent by Schering-Plough Corporation approved for the treatment of brain tumors by the FDA since 1999. ... AboutLawsuits.com Seve Ballesteros Looks To Beat Brain Cancer As His Charitable Foundation Comes ... - Dec 16, 2009 Temozolomide has proved to be an effective treatment for people with this type of brain tumour who would otherwise have very limited treatment options. ... Medical News Today (press release) CHMP backs Amgen's Prolia and GSK's ITP drug - Dec 21, 2009 Positive opinions were also adopted for Novartis and Hospira's generic versions of Schering-Plough's Temodal (temozolomide) for glioblastoma and extensions ... Pharma Times Vermonter loses his sight but gains new vision - Dec 21, 2009 The temozolomide capsules he took at home appeared no different from any other prescription pill. But they were so poisonous, his family was prohibited from ... Barre Montpelier Times Argus Phase Forward's InForm Global Trial Management solution standardized to ... - Dec 16, 2009 The organization has pioneered the development of some of the most novel anti-cancer treatments in the marketplace, such as temozolomide, widely recognized ... News-Medical.net TUMORI CEREBRALI: PIU' RADIO E CHEMIO CON MENO RISCHI - Dec 21, 2009 La terapia standard prevede l intervento chirurgico el uso di radiazioni dirette contro il cancro e da cicli di chemioterapia con temozolomide, ... AGI - Agenzia Giornalistica Italia Nuovo metodo radiochemio antitumori - Dec 21, 2009 ...associando al trattamento radioterapico la chemioterapia con 'Temozolomide', contro una delle piu' aggressive forme di cancro del cervello. ANSA CBG: positief advies voor DuoCover, negatief advies voor Cerepro - Dec 24, 2009 Het Comité heeft positieve adviezen uitgebracht voor drie geneesmiddelen met als werkzame stof temozolomide. Het gaat om generieke versies van Temodal dat ... Medical facts Ascenta Therapeutics Announces Presentation of Results From a Dose-Ranging ... - Oct 26, 2009 ..."Our results suggest that AT-101 used in combination with temozolomide and radiation therapy may help extend the lives of patients with this very aggressive ... Reuters Thirteen Abstracts Featuring Exelixis Compounds Accepted for Presentation at ... - Nov 4, 2009 ...a novel PI3K/TORC1/TORC2 inhibitor, in combination with temozolomide (TMZ) in patients (pts) with malignant glioma will be presented on Tuesday, ... Reuters TRACON Pharmaceuticals Announces Upcoming Presentation of Clinical Data on ... - Nov 9, 2009 TRC102 is currently being studied as an oral agent in combination with pemetrexed (Alimta(R)) and as an intravenous agent in combination with temozolomide ... GlobeNewsWire (press release) Data Presented on Oncophage Cancer Vaccine in Recurrent Glioma at SNO 2009 - Oct 26, 2009 An additional Phase 2 study is underway evaluating Oncophage in combination with Temodar (temozolomide) in newly diagnosed glioma patients. ... Reuters ImmunoCellular Therapeutics Presents Data from Phase I Trial of ICT-107 ... - Oct 27, 2009 ...in addition to standard treatment with radiation and temozolomide, a chemotherapy product that was until recently the only approved drug for GBM. ... Reuters Exelixis, Inc. Q3 2009 Earnings Call Transcript - Oct 29, 2009 We also recently initiated a phase 1b dose ranging study of XL184 in combination with Temozolomide and radiation therapy in first line GBM patients. ... Seeking Alpha (blog) Merck & Co earnings climb as Januvia and Isentress impress - Oct 23, 2009 The brain cancer drug Temodar (temozolomide) increased 2% to $278 million, though the hepatitis C treatment PegIntron (pegylated interferon) decreased 6% to ... Pharma Times Antigenics Reports Third Quarter 2009 Financial Results - Oct 29, 2009 ...trial of Oncophage in combination with the standard of care - radiation therapy plus Temodar® (temozolomide) - for newly diagnosed glioma patients. ... Reuters Health Canada approves Antisense Pharma's clinical Phase III study SAPPHIRE in ... - Oct 19, 2009 Trabedersen is being investigated as monotherapy compared to current standard therapy with temozolomide (alternatively BCNU (carmustine)). ... CNW Telbec (Communiqué de presse) Radiotherapy plus adjuvant temozolomide for the treatment of … - Apr 11, 2005 Stupp R et al. (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352: 987–996 PubMed ... Nature.com Temozolomide as salvage treatment in primary brain lymphomas - Feb 27, 2007 Correspondence: Dr M Reni, Department of Oncology, San Raffaele Scientific. Institute. - via Olgettina 60, Milan 20132, Italy. E-mail: reni.michele@hsr.it ... Nature.com Brain Tumor - Children Chemotherapy - Brain Tumor - Children Health … - Jun 10, 2008 Temozolomide, the first new drug approved for brain tumors in several decades, ... Temozolomide was first approved in 1999 for adult patients with ... New York Times A Phase I/II study of lomustine and temozolomide in patients with... - Aug 8, 2006 Temozolomide is an alkylating agent with activity in the treatment of melanoma metastatic to the brain. Lomustine is a nitrosurea that crosses the blood ... Nature.com … of extended dosing with lomeguatrib with temozolomide in patients... - Sep 11, 2008 Lomeguatrib for 10 days with temozolomide 75 mg m -2 was established as the optimal ... Extending lomeguatrib administration beyond that of temozolomide ... Nature.com New hope against brain tumors - Mar 9, 2005 For now, she advises, doctors should give temozolomide to all patients with this tumor because it helps some and causes few dangerous problems. USA Today Drug Shrinks Some Brain Tumors - May 22, 2007 The patients were treated with temozolomide for up to 30 months. Brain tumors shrank in 53 percent of patients and stabilized in 37 percent of patients. ... Washington Post Where there's a will there's a way to get banned cancer drug - Sep 14, 2006 Temozolomide is widely used in Europe and America to treat primary brain ... “NICE has not yet reached a final decision on the use of temozolomide in the ... Times Online Drug Shrinks Some Brain Tumors - May 21, 2007 The patients were treated with temozolomide for up to 30 months. Brain tumors shrank in 53 percent of patients and stabilized in 37 percent of patients. ... ABC News Missing Chromosome Improves Response to Brain Tumor Treatment - Feb 18, 2008 ..."Temozolomide is now our first choice of treatment for patients with gliomatosis cerebri, especially when missing chromosomes 1p and 19q," Dr. Marc Sanson ... ABC News Is single-agent temozolomide the treatment of choice for recurrent... - May 3, 2007 Reni M et al. (2007) Temozolomide as salvage treatment in primary brain lymphomas. Br J Cancer 96: 864–867 PubMed. Methotrexate-based chemotherapy is the ... Nature.com Doctors demand brain cancer drugs - Feb 23, 2006 They say the treatments, temozolomide and carmustine implants, ... It has been estimated that temozolomide alone could potentially benefit 800 patients a ... BBC News Cancer vaccine 'doubles average survival time' - Jun 3, 2008 The addition of temozolomide was a radical step, because normally chemotherapy drugs suppress the immune system. They would therefore be expected to make ... Telegraph.co.uk A phase II trial of lomeguatrib and temozolomide in metastatic... - May 13, 2008 Correspondence: Dr MR Middleton, Cancer Research UK Medical Oncology Unit, Churchill Hospital, Oxford OX3 7LJ, UK. E-mail: mark.middleton@cancer.org.uk ... Nature.com Does addition of temozolomide to whole brain radiotherapy improve … - Feb 14, 2005 Verger E et al. (2005) Temozolomide and concomitant whole brain radiotherapy in patients with brain metastases: a phase II randomized trial. ... Nature.com A Gray Day For Array - Dec 20, 2007 ...based company announced that its latest cancer drug tests proved the treatment to be relatively ineffective in comparison to temozolomide, an oral cancer ... Forbes Temozolomide (Systemic).(Drug overview) - May 1, 2006 Temozolomide ( tem-oh-ZOHL-oh-mide) belongs to the general group of medicines known as antineoplastics. It is used to treat specific types of cancer of the ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com … Recommends Approval of TEMODAL(R) (Temozolomide) for the Most … - Apr 25, 2005 Schering-Plough Corporation (NYSE: SGP) reported that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has ... i-newswire.com Brain tumour patient is denied vital drug - Feb 24, 2006 ..."That was when we were told Temozolomide was a breakthrough drug but we ... Experts have estimated that Temozolomide alone could potentially benefit 800 ... WalesOnline Long-Term Results Confirm Temozolomide Prolongs Survival in Brain … - Oct 30, 2007 By Ed Susman. LOS ANGELES, CA -- October 30, 2007 -- Updated data reveal that patients who receive the combination of radiation and temozolomide for ... DG News FDA Approvals: Temodar, LR3001, Xopenex HFA - Mar 17, 2005 On March 15, the FDA approved a new indication for temozolomide capsules ... Results showed that addition of concomitant and maintenance temozolomide to ... Medscape FDA approves Temodar (temozolomide) as treatment for patients with … - Mar 16, 2005 Schering-Plough Corp reported that the US Food and Drug Administration (FDA) has granted approval for Temodar (temozolomide) Capsules for use in combination ... Free with registration - Asia Africa Intelligence Wire - AccessMyLibrary.com … Multiforme - Health Canada Approves TEMODAL(R) (temozolomide) - Feb 6, 2006 Schering-Plough markets temozolomide in the United States as TEMODAR(R) Capsules. ... The development of temozolomide for additional markets and expanded ... Medical News Today - Medical News Today (press release) A phase II study of temozolomide therapy for poor-risk patients aged... - Jan 25, 2007 Standard induction chemotherapy for acute myeloid leukemia (AML), using cytarabine plus an anthracycline, results in complete remission (CR) in about 55% of ... Nature.com Temozolomide Not Superior to Procarbazine-Based Combination … - Sep 18, 2008 By Ed Susman. STOCKHOLM, Sweden -- September 18, 2008 -- Treating patients with temozolomide monotherapy is not more effective than the standard therapy of ... DG News New drug slows deadly brain cancer, experts say - Mar 11, 2005 Researchers compared patients treated with radiation and temozolomide to those who ... While not a cure, the drug temozolomide marks the first advance in ... Pay-Per-View - The Record - ProQuest Archiver TEMOZOLOMIDE (Oral route) - te-moe-ZOE-loe-mide.(Drug overview) - May 1, 2007 Temozolomide belongs to the general group of medicines known as antineoplastics. It is used to treat specific types of cancer of the brain in adults whose ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com Prolonged Lymphopenia Common with Long-Term Temozolomide for … - Mar 9, 2006 NEW YORK MAR 09, 2006 (Reuters Health) - In patients with glioma, long-term temozolomide therapy is commonly associated with prolonged, ... Cancerpage.com Temozolomide Improves Survival in Glioma: Presented at ECCO - Oct 31, 2005 By Jill Stein. PARIS, FRANCE -- October 31, 2005 -- The addition of temozolomide to conventional radiotherapy for high-grade glioma prolongs overall ... DG News … Promoter Agent Indicates Which Patients Will Benefit from Temozolom... - Apr 22, 2005 By comparison, in patients whose MGMT was active, temozolomide plus radiation ... "MGMT methylation is a predictive factor for benefit from temozolomide, ... DG News Lomeguatrib Does Not Improve Temozolomide Treatment of Metastatic … - Jul 9, 2007 By Will Boggs, MD. NEW YORK JUL 09, 2007 (Reuters Health) - For patients with metastatic cutaneous melanoma, the current dosing schedule of lomeguatrib does ... Cancerpage.com Health Canada Approves Temodal (Temozolomide) for Patients With … - Feb 2, 2006 KENILWORTH, NJ -- February 2, 2006 -- Schering-Plough Corporation today reported that Health Canada has granted approval for TemodalŽ (temozolomide) ... DG News Phase III: temozolomide fails to improve melanoma survival.(News) | … - Nov 1, 2008 Phase III: temozolomide fails to improve melanoma survival.(News) ... find Skin & Allergy News articles. STOCKHOLM -- Extended-schedule, escalated-dose ... Pay-Per-View - Skin & Allergy News - HighBeam Research … Recommends Approval of TEMODAL(R) (Temozolomide) for the Most … - Apr 22, 2005 Schering-Plough received full approval of temozolomide (TEMODAR(R)) from the US ... The development of temozolomide for expanded indications is consistent ... Free with registration - PR Newswire Europe - AccessMyLibrary.com Is Temozolomide the Treatment of Choice for Recurrent Primary CNS … - Sep 11, 2007 Is Single-Agent Temozolomide the Treatment of Choice for Recurrent Primary Central Nervous System Lymphoma? Background: Methotrexate-based chemotherapy is ... Medscape Vaccine Therapy Appears Promising in Glioblastoma Multiforme - Apr 26, 2006 Despite the recent addition of temozolomide ( Temodar) chemotherapy to ... That trial will test the vaccine with concurrent ongoing temozolomide therapy. ... Medscape A Phase II Study of Thalidomide and Temozolomide in Patients With... - Sep 7, 2008 BACKGROUND: CNS metastases develop in nearly half of patients with advanced melanoma and in 15-20 % CNS is the first site of relapse. ... ecancermedicalscience Temodar (temozolomide) Capsules - Mar 15, 2005 New Indication: Temodar (temozolomide) capsules is approved for the treatment of patients with newly diagnosed high-grade gliomas concomitantly with ... Medscape TEMODAL(R) Approved By Japan's Ministry of Health, Labor and Welfare ... - Jul 31, 2006 After a 4-week rest period, temozolomide monotherapy is started at 150 mg/m2 orally ... The development of temozolomide for additional markets and expanded ... RedOrbit Treatment Advances for Glioblastoma: Tumor Markers and Targeted … - Jun 1, 2007 1 However, since 2005 the standard of treatment has changed thanks to studies showing positive results from daily temozolomide (Temodar) combined with ... Psychiatric Times Common virus may serve as target for deadly brain tumour vaccine - May 18, 2008 ..."We believe that use of temozolomide can further stimulate immune response to the vaccine because it initially depletes the infection-fighting immune cells. ... thecheers.org … Multiforme; FDA approves TEMODAR (temozolomide) for patients with ... - Apr 16, 2005 2005 APR 16 - (NewsRx.com) -- Schering-Plough Corp. (SGP) reported that the US Food and Drug Administration (FDA) has granted approval for TEMODAR ... Pay-Per-View - Obesity, Fitness & Wellness Week - Factiva, from Dow Jones Temozolomide Effective for Brain Tumor Treatment: Presented at ICACT - Feb 8, 2007 By Jill Stein. PARIS, FRANCE -- February 8, 2007 -- The oral alkylating agent temozolomide (Temodar) has shown favorable results in a small study of adults ... DG News Gliadel(R) Wafer Clinical Data Presented at Society for Neuro... - Nov 20, 2006 Interim data from 35 patients with this aggressive brain tumor showed a median survival of 18.6 months when Gliadel Wafer and temozolomide are used in ... Free with registration - PR Newswire - AccessMyLibrary.com Gliadel® Wafer Plus Temozolomide Show Promising Results in High … - May 18, 2005 By Guilford Pharmaceuticals Inc., [RxPG] Guilford Pharmaceuticals Inc. today announced findings from a study of GLIADEL(R) Wafer (polifeprosan 20 with ... RxPG NEWS Temozolomide Effective Against Low-Grade Gliomas - May 23, 2007 May 23, 2007 — Data from a retrospective review of a large single-center experience confirm that treatment with temozolomide (TMZ; Temodar, Temodal, ... Medscape … : Health Canada Approves TEMODAL(R)(temozolomide) for Patients With... - Feb 2, 2006 Health Canada Approves TEMODAL(R)(temozolomide) for Patients With Newly Diagnosed Glioblastoma Multiforme. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Ark Therapeutics' treatment for malignant glioma Cerepro meets... - Jul 30, 2008 On the primary endpoint, the Cerepro with temozolomide group showed an improvement ... Improvements in the combined Cerepro and temozolomide treatment group ... $9.94 - M2 Europharma - Alacra Store … Release: FDA Approves TEMODAR(R) (temozolomide) as Treatment for … - Mar 16, 2005 FDA Approves TEMODAR(R) (temozolomide) as Treatment for Patients With Newly Diagnosed Glioblastoma Multiforme; Schering-Plough Receives Full Approval for ... Pay-Per-View - PR Newswire - HighBeam Research Guidelines: Carmustine Implants and Temozolomide for Treatment of … - Aug 23, 2007 August 23, 2007 -- The following is a summary of the major recommendations from the National Institute for Health and Clinical Excellence (NICE) entitled, ... DG News Cancer Therapy; Temozolomide demonstrated moderate activity in … - Oct 24, 2006 According to recently published research from South Korea, "Numerous studies have demonstrated the clinical activity of temozolomide, a second-generation ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Schering-Plough and Oncomethylome Sciences announce collaboration … - Nov 16, 2005 The development of temozolomide for additional markets and expanded indications is ... There may be a higher occurrence of PCP when temozolomide is ... carolinanewswire.com Myriad Genetics Initiates Phase 2 Clinical Trial of Azixa in Metastati... - Mar 27, 2007 The trial will compare the survival of patients treated with Azixa to those treated with temozolomide or the combination of Azixa plus temozolomide. ... Genetic Engineering News - Genetic Engineering News (press release) New indication for Temodar.(Temozolomide drug approval)(Brief Article) - Apr 4, 2005 Temozolomide (Temodar, Schering-Plough) has been approved for use ... Temozolomide was previously approved for the treatment of anaplastic astrocytoma. Free with registration - Drug Topics - AccessMyLibrary.com Cancer Therapy; O-6-benzylguanine and temozolomide used to treat … - Jan 10, 2006 2006 JAN 10 - (NewsRx.com) -- O-6-benzylguanine (O6BG) and temozolomide (TMZ) were used to treat pediatric patients with solid tumors. ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Temozolomide.(FAD actions in brief)(Brief Article) - Apr 1, 2005 Temozolomide (Temodar, Schering-Plough) was approved for use in combination with radiotherapy for the treatment of adult patients with newly diagnosed ... Free with registration - Formulary - AccessMyLibrary.com … Recommends Approval of TEMODAL(R) (Temozolomide) for the Most … - Apr 22, 2005 European Union's CHMP Recommends Approval of TEMODAL(R) (Temozolomide) for the Most Common and Aggressive Form of Brain Cancer. ... find PR Newswire Europe ... Pay-Per-View - PR Newswire Europe - HighBeam Research … Opinions: Primary Brain Cancer - Temozolomide Turns Heads" by … - Aug 19, 2005 ..."Stakeholder Opinions: Primary Brain Cancer - Temozolomide Turns Heads" by Datamonitor August 2005. from M2 Presswire. Highbeam Research – FREE Trial. Pay-Per-View - M2 Presswire - HighBeam Research Chasing down brain tumor wildfires - Jun 4, 2008 Patients also start a daily dose of chemotherapy called temozolomide, ... Unlike some other forms of chemotherapy, temozolomide usually does not cause ... Boston Globe Research and Markets: Temozolomide Turns Heads in the Field of Brain ... - Jul 15, 2005 DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets. com/reports/c20845) has announced the addition of Stakeholder Opinions: Primary Brain ... $4.95 - Business Wire - ECNext … syndrome resulted after temozolomide treatment for glioma - Apr 25, 2005 We report a 44-year-old woman with t-MDS (refractory anemia with excess blasts) following treatment of recurrent anaplastic astrocytoma with temozolomide ... Pay-Per-View - Health & Medicine Week - Factiva, from Dow Jones … syndrome resulted after temozolomide treatment for glioma - Apr 25, 2005 We report a 44-year-old woman with t-MDS (refractory anemia with excess blasts) following treatment of recurrent anaplastic astrocytoma with temozolomide ... Pay-Per-View - Hematology Week - Factiva, from Dow Jones … syndrome resulted after temozolomide treatment for glioma - Apr 26, 2005 We report a 44-year-old woman with t-MDS (refractory anemia with excess blasts) following treatment of recurrent anaplastic astrocytoma with temozolomide ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones … syndrome resulted after temozolomide treatment for glioma - Apr 26, 2005 We report a 44-year-old woman with t-MDS (refractory anemia with excess blasts) following treatment of recurrent anaplastic astrocytoma with temozolomide ... Pay-Per-View - Science Letter - Factiva, from Dow Jones … syndrome resulted after temozolomide treatment for glioma - Apr 25, 2005 We report a 44-year-old woman with t-MDS (refractory anemia with excess blasts) following treatment of recurrent anaplastic astrocytoma with temozolomide ... Pay-Per-View - Clinical Trials Week - Factiva, from Dow Jones … Opinions: Primary Brain Cancer - Temozolomide Turns Heads" by... - Aug 19, 2005 Schering-Plough's temozolomide has gained approval as first line therapy for glioblastoma ... Temozolomide has raised the bar for other agents and, as such, ... $4.95 - M2 Presswire - ECNext Chemotherapy; Irinotecan plus temozolomide was well tolerated in … - Nov 15, 2005 2005 NOV 15 - (NewsRx.com) -- Irinotecan (CPT-11) plus temozolomide (TMZ) was well tolerated in patients with recurrent malignant glioma (MG). ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones … : Health Canada Approves TEMODAL(R)(temozolomide) for Patients With... - Feb 2, 2006 Health Canada Approves TEMODAL(R)(temozolomide) for Patients With Newly Diagnosed Glioblastoma Multiforme. from PR Newswire Europe. Pay-Per-View - PR Newswire Europe - HighBeam Research Brain Cancer; NDA submitted in Japan for temozolomide capsules to... - Nov 29, 2005 2005 NOV 29 - (NewsRx.com) -- Schering-Plough Corporation (SGP) announced that Schering-Plough KK, the company's country operation in Japan, has submitted a ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones … Multiforme; FDA approves TEMODAR (temozolomide) for patients with ... - Apr 12, 2005 2005 APR 12 - (NewsRx.com) -- Schering-Plough Corp. (SGP) reported that the US Food and Drug Administration (FDA) has granted approval for TEMODAR ... Pay-Per-View - Science Letter - Factiva, from Dow Jones temozolomide Schering Plough receives EU approval for first-line … - Jun 20, 2005 Schering Plough announced on 10 June 2005 that the EMEA has approved temozolomide (TEMODAL) in the EU, Iceland and Norway for use in the first-line ... Pay-Per-View - R & D Focus Drug News - Factiva, from Dow Jones TEMODAL(R) Approved in European Union For Treatment of Newly … - Jun 10, 2005 The development of temozolomide for expanded indications is consistent with ... There may be a higher occurrence of PCP when temozolomide is administered ... $4.95 - PR Newswire - ECNext … Multiforme; FDA approves TEMODAR (temozolomide) for patients with ... - Apr 15, 2005 2005 APR 15 - (NewsRx.com) -- Schering-Plough Corp. (SGP) reported that the US Food and Drug Administration (FDA) has granted approval for TEMODAR ... Pay-Per-View - Drug Week - Factiva, from Dow Jones Neopharm Brain Tumor Drug Safe, Study Shows - Nov 21, 2006 CED of Cintredekin Besudotox at the highest dose followed by EBRT with or without concurrent temozolomide was shown to be well-tolerated in patients. ... RedOrbit VICAL SETS SPA, READIES FOR ALLOVECTIN-7 PHASE III TRIAL.(Vical … - Feb 11, 2005 Vical said the Phase III trial will compare response rates of patients who receive Allovectin-7 to chemotherapeutic agents dacarbazine or temozolomide. ... Pay-Per-View - BIOWORLD Today - Factiva, from Dow Jones Case Western Reserve University licenses methoxyamine to Tracon - Oct 13, 2006 The patented therapy, which has been licensed to TRACON, has been studied most intensively in combination with the approved chemotherapeutic Temozolomide. ... eurekalert.org GlobeNewswire, Inc. - News Room - Mar 15, 2005 MRI determination of Temozolomide treatment response in a tv-atransgenic model of glioma. Patrick McConville, et al. Abstract number: 3787; Poster Session ... primezone.com PATIENTS PLEAD FOR DRUG FUNDS - Jul 5, 2005 But in New Zealand temozolomide, sold as Temodal, is not funded and is licensed to ... Patients in Australia now pay just $28.60 a month for temozolomide ... Pay-Per-View - Dominion Post - Factiva, from Dow Jones Sen. Ted Kennedy Leaves Hospital - May 21, 2008 The oral chemotherapy drug temozolomide (Temodar) has also become part of that initial plan that has been shown to be the most promising treatment. ... WebMD Research to benefit patients, not doctors - Feb 9, 2007 Temozolomide was discovered by Cancer Research UK and is designed specifically ... In 2003 temozolomide was one of three new cancer treatments that Cancer ... Times Online 腦瘤用藥å?¥ä¿?放寬給付 - Jan 8, 2008 ...å?¥ä¿?局擴大腦癌化療用藥Temozolomide給付方å¼?ï¼Œå¾žå…ƒæœˆèµ·ï¼Œè¢«è¨ºæ–·ç‚ºå¤šåž‹æ€§ç¥žç¶“è† è³ªç´°èƒž 瘤的腦瘤患者在手術後，接å?—放射治療時，å?¯ä»¥å?Œæ¥ä½¿ç”¨Temozolomide。 ... è?¯å?ˆæ–°è?žç¶² Combo Tx for melanoma lacks survival advantage.(Clinical Rounds) - Jul 1, 2005 VIENNA -- Combination therapy with the brain cancer drug temozolomide and ... In the study of temozolomide, the overall response rate was about 26% in ... Free with registration - Skin & Allergy News - AccessMyLibrary.com Spinal metastasis in glioblastoma multiforme: a case study.(Clinical... - Feb 1, 2007 At the same time, she started continuous daily oral temozolomide, ... At that time, she was started on oral temozolomide, 150 mg per square meter of BSA, ... $4.95 - Journal of Neuroscience Nursing - ECNext New beginnings for brain cancer treatment. - Jul 27, 2005 L), the recent supplementary approval of Schering-Plough's temozolomide ... In March 2005 temozolomide garnered US FDA approval for the first-line treatment ... $4.95 - M2 Presswire - ECNext CHMP Recommends Approval In The European Union (EU) For New … - Dec 9, 2008 TEMODAR capsules (temozolomide) received accelerated approval from the US Food and Drug ... There may be a higher occurrence of PCP when temozolomide is ... Medical News Today - Medical News Today (press release) Preliminary Cerepro (R) Phase III Results Meet Primary Endpoint - … - Aug 1, 2008 This allowed comparison of the efficacy of Cerepro (R) and temozolomide in the ... On the primary endpoint, the group given Cerepro (R) and temozolomide ... Medical News Today - Medical News Today (press release) RTOG Study Likely Treatment Option for Brain Tumor Patients Like Sen.... - May 22, 2008 The goal of the study is find out if giving temozolomide for a longer ... Enrolled patients take a daily dose of temozolomide orally during radiotherapy. ... RedOrbit 'Politicians are going to have to grasp the nettle of health reform' - Apr 3, 2006 A European study found that when Temozolomide was prescribed to newly ... The total UK-wide annual cost to the NHS of introducing Temozolomide as a ... Scotsman Tapestry Pharmaceuticals Presents Data on TPI 287 at the AACR Annual ... - Apr 15, 2007 Increases the efficacy of temozolomide in glioblastoma In an orthotopic brain xenograft study using the U251 glioblastoma cell line, a combination of low ... Free with registration - PR Newswire - AccessMyLibrary.com Oncolytic Virus Works With Alkylating Agent to Destroy Glioma Cells - Jan 4, 2006 Temozolomide was approved as a treatment for newly diagnosed glioblastoma in ... In short, temozolomide would induce tumor-protective DNA repair pathways ... Cancerpage.com PHARMAC agrees funding for brain tumour treatment - Apr 3, 2006 Funding for temozolomide (Temodal) has been approved by PHARMAC for patients who ... It shows that temozolomide can make a difference for patients who have ... scoop.co.nz Press Release: New beginnings for brain cancer treatment. - M2 … - Jul 27, 2005 L), the recent supplementary approval of Schering-Plough's temozolomide ... In March 2005 temozolomide garnered US FDA approval for the first-line treatment ... Pay-Per-View - M2 Presswire - HighBeam Research Combo Tx for melanoma lacks survival advantage.(Clinical Rounds) | … - Jul 1, 2005 VIENNA -- Combination therapy with the brain cancer drug temozolomide and interferon alfa increased response ... Pay-Per-View - Skin & Allergy News - HighBeam Research Press Release: Long-Term Data from a Landmark Phase III Trial Show … - Oct 30, 2007 ..."In 2004, the data demonstrated that temozolomide therapy, taken during and ... "In 2004, the addition of temozolomide to radiotherapy demonstrated a ... Pay-Per-View - PR Newswire - HighBeam Research EPICEPT: MYRIAD INITIERAR TREDJE FAS II-STUDIE MED AZIXA - Aug 16, 2007 I studien pÃ¥ icke smÃ¥cellig lungcancer kommer patienter att lottas till behandling med enbart Azixa, temozolomide, eller Azixa i kombination med ... Dagens Nyheter Gynecology; Recent studies add new data to gynecology research - Apr 4, 2005 According to a study from England, "temozolomide is an alkylating agent that ... Thus, growth of cells treated only with temozolomide (5 mcg/mL) was 91% of ... Pay-Per-View - Clinical Oncology Week - Factiva, from Dow Jones PHARMAC, Schering-Plough reach agreement - Mar 2, 2006 The proposal PHARMAC is consulting on would see temozolomide funded for newly-diagnosed glioblastoma multiforme patients who were undergoing radiotherapy. ... scoop.co.nz NeoPharm's Cintredekin Besudotox Well-Tolerated in Newly Diagnosed … - Apr 25, 2006 Three patients treated at 0.5 ug/mL + radiation + temozolomide have completed the safety observation without any DLT. Two additional patients are currently ... Free with registration - Business Wire - AccessMyLibrary.com Gynecology; Simultaneous blockade of Bcl-2 and DNA repair staunches … - Jan 1, 2005 According to a study from England, "temozolomide is an alkylating agent that ... Thus, growth of cells treated only with temozolomide (5 mcg/mL) was 91% of ... Pay-Per-View - Obesity, Fitness & Wellness Week - Factiva, from Dow Jones Hersentumoren : temozolomide voortaan terugbetaald - May 1, 2006 Op 1 mei 2006 is een wet van kracht geworden waardoor temozolomide voortaan wordt terugbetaald. Temozolomide wordt gebruikt bij de behandeling van ... E-Gezondheid Brand Names/Synonyms: Temozolomide is also known by the following brand names and/or synonymsAIDS-129717; AIDS129717; CHEMBANK1819; Methazolastone; NSC362856; Temodal; Temodar; Temozolamide; Temozolodida [Spanish]; Temozolomide; Temozolomide [Ban:Inn]; Temozolomidum [Latin] Drug Category: Temozolomide is categorized under the following by the FDA: Antineoplastic Agents; ATC:L01AX03 Dosage Forms: CAPSULE Absorption: Rapid and complete absorption in the gastrointestinal tract Interactions: [an error occurred while processing this directive] Chemical IUPAC Name: 4-methyl-5-oxo-2,3,4,6,8-pentazabicyclo[4.3.0]nona-2,7,9-triene-9-carboxamide |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |